28/01/2021
Read the European Biotech Associations Letter to the European Commission regarding the ongoing evaluation of the Orphan Medicinal Products Regulation.
20/01/2021
Read our submission to the European Commission’s Inception Impact Assessment titled “Revision of the EU legislation on medicines for children and rare diseases“.
24/12/2020
30/11/2020
Call for more effective EU regulation of clinical trials with Advanced Therapy
Medicinal Products consisting of or containing Genetically Modified Organisms
25/11/2020
EuropaBio looks forward to working closely with the European institutions to ensure the Pharmaceutical Strategy delivers for European patients and establishes a framework that enables a successful life sciences sector for the medium to long-term.
02/11/2020
EuropaBio announces Dr. Claire Skentelbery as new Director General of the Association.
20/10/2020
EuropaBio Position Paper on the use of Real-World Data (RWD) and Real-World Evidence (RWE) for regulatory decision-making.
19/10/2020
EuropaBio and its members would like to engage the European Commission and all relevant stakeholders in a discussion on the future use of the HE in the context of the new EU Pharmaceutical Strategy and its accompanying actions.
07/10/2020
Brussels, 7 October 2020: Today, genome editing pioneers Emmanuelle Charpentier and Jennifer A. Doudna have been awarded the Nobel Prize in Chemistry 2020
30/09/2020
EuropaBio Patient engagement with the European Medicines Agency
24/08/2020
This is a non-exhaustive list of over 200 genome-editing or viral vector related products and research projects, drawn from various resources and covering healthcare, industrial and agricultural biotech
13/08/2020
Read our Statement in response to the publication of the European Commission’s evaluation of the Orphan and Paediatric Regulations.
03/08/2020
Health industry sectors, representing pharmaceutical and medical technology companies welcome the publication of the Partnership Proposal as a significant milestone towards a European Partnership for Health Innovation.
30/07/2020
Joint response of EuropaBio and BIO on the EU Data Strategy Consultation.
30/07/2020
EuropaBio response to the public consultation on the Roadmap for an EU Pharmaceutical Strategy.
30/07/2020
Read our response on the eHSG Work Programme 2020-2022.
30/06/2020
EuropaBio welcomes the European Commission’s commitment to develop a European plan to fight cancer and is supportive of its overarching approach in tackling all key stages of the disease: prevention, early diagnosis, treatment, and quality of life. Above all, we strongly advocate the employment of supportive measures for health innovation to ensure that novel cancer treatments move from the laboratory to the hospital bedside as swiftly as possible.
19/06/2020
We do appreciate the efforts led by the FAIR Initiative and hope to continue to partner with ACCELERATE to speed up the delivery of innovative therapies to children and adolescents.
17/06/2020
The pharmaceutical and biotechnology industries are doing everything in their power to prepare for all scenarios and need the support of the European Union to ensure that we can fulfil our promise to the patients who we serve.
20/05/2020
Read our latest blog on the impact of the pandemic on patients with chronic diseases and rare conditions around the globe.